Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
We cover the essential inputs used to calculate the Dow Jones, including component prices and the divisor, and explain how calculations translate to the index.
6,843 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
Two real estate ETFs take opposite paths: one spreads bets worldwide, the other bets on the U.S. market. Learn how HA...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
Zenith Labs announced a new cross-chain bridge that lets the Canton network and Ethereum swap tokens via atomic swaps...
Shay Capital reduced its PureCycle stake in the latest 13F filing, prompting questions about the stock's future. This...
Global markets face renewed volatility as geopolitics and energy prices swing. CEOs are adopting a wartime mindset, r...
As hurricane risk and losses climb, lenders are expanding financing options for these round homes resilient designs, ...
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
SpaceX is one of the most anticipated names in tech and aerospace. This guide shows everyday investors how to beat wa...
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...